Your search returned 1590 results.

Results
	701.	The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro. [electronic resource] by Becker, Marie N Wu, Kevin J Marlow, Laura A Kreinest, Pamela A Vonroemeling, Christina A Copland, John A Williams, Christopher R Producer: 20141121 In: Urologic oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	702.	Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab). [electronic resource] by Ho, Diep Huang, Jessica Chapman, Judith-Anne W Leitzel, Kim Ali, Suhail M Shepherd, Lois Parulekar, Wendy R Ellis, Catherine E Crescnzo, Rocco J Zhu, Liting Virk, Shakeel Nomikos, Dora Aparicio, Samuel Gelmon, Karen A Carney, Walter P Lipton, Allan Producer: 20180126 In: Breast cancer research and treatment vol. 164 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	703.	Clinical studies with non-iressa EGFR tyrosine kinase inhibitors. [electronic resource] by Bonomi, Philip Producer: 20031118 In: Lung cancer (Amsterdam, Netherlands) vol. 41 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	704.	Medicinal chemistry strategies in follow-on drug discovery. [electronic resource] by Zhao, Hongyu Guo, Zongru Producer: 20090728 In: Drug discovery today vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	705.	Cardiac toxicity of ErbB2-targeted therapies: what do we know? [electronic resource] by Perez, Edith A Producer: 20080930 In: Clinical breast cancer vol. 8 Suppl 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	706.	mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). [electronic resource] by Vázquez-Martín, Alejandro Oliveras-Ferraros, Cristina del Barco, Sonia Martín-Castillo, Begoña Menéndez, Javier A Producer: 20091223 In: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	707.	18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. [electronic resource] by Gebhart, Geraldine Gámez, Cristina Holmes, Eileen Robles, Javier Garcia, Camilo Cortés, Montserrat de Azambuja, Evandro Fauria, Karine Van Dooren, Veerle Aktan, Gursel Coccia-Portugal, Maria Antonia Kim, Sung-Bae Vuylsteke, Peter Cure, Hervé Eidtmann, Holger Baselga, José Piccart, Martine Flamen, Patrick Di Cosimo, Serena Producer: 20140106 In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	708.	Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancer. [electronic resource] by Zardavas, Dimitrios Bozovic-Spasojevic, Ivana de Azambuja, Evandro Producer: 20130328 In: Current opinion in oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	709.	Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer. [electronic resource] by Lee, Chee Khoon Davies, Lucy Gebski, Val J Lord, Sarah J Di Leo, Angelo Johnston, Stephen Geyer, Charles Cameron, David Press, Michael F Ellis, Catherine Loi, Sherene Marschner, Ian Simes, John de Souza, Paul Producer: 20160715 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	710.	Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer. [electronic resource] by Ni, Yingjia Schmidt, Keon R Werner, Barnes A Koenig, Jenna K Guldner, Ian H Schnepp, Patricia M Tan, Xuejuan Jiang, Lan Host, Misha Sun, Longhua Howe, Erin N Wu, Junmin Littlepage, Laurie E Nakshatri, Harikrishna Zhang, Siyuan Producer: 20190819 In: Nature communications vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	711.	Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients. [electronic resource] by Lambertini, Matteo Campbell, Christine Bines, José Korde, Larissa A Izquierdo, Miguel Fumagalli, Debora Del Mastro, Lucia Ignatiadis, Michail Pritchard, Kathleen Wolff, Antonio C Jackisch, Christian Lang, Istvan Untch, Michael Smith, Ian Boyle, Frances Xu, Binghe Barrios, Carlos H Baselga, José Moreno-Aspitia, Alvaro Piccart, Martine Gelber, Richard D de Azambuja, Evandro Producer: 20200311 In: Journal of the National Cancer Institute vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	712.	Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity. [electronic resource] by Shrivastava, Richa Trivedi, Shruti Singh, Pankaj Kumar Asif, Mohammad Chourasia, Manish Kumar Khanna, Amit Bhadauria, Smrati Producer: 20181217 In: Biochemical and biophysical research communications vol. 503 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	713.	Lapatinib in metastatic breast cancer. [electronic resource] by Frenel, J-S Bourbouloux, E Berton-Rigaud, D Sadot-Lebouvier, S Zanetti, A Campone, M Producer: 20100111 In: Women's health (London, England) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	714.	Targeting breast cancer stem cells. [electronic resource] by Wicha, Max S Producer: 20100420 In: Breast (Edinburgh, Scotland) vol. 18 Suppl 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	715.	Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumors. [electronic resource] by Kawada, Kenji Murakami, Koji Sato, Takashi Kojima, Yoshiki Ebi, Hiromichi Mukai, Hirofumi Tahara, Makoto Shimokata, Kaoru Minami, Hironobu Producer: 20071022 In: Japanese journal of clinical oncology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	716.	Systemic therapies for recurrent and/or metastatic salivary gland cancers. [electronic resource] by Vattemi, Emanuela Graiff, Claudio Sava, Teodoro Pedersini, Rebecca Caldara, Alessia Mandarà, Marta Producer: 20080626 In: Expert review of anticancer therapy vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	717.	Mechanism of activation and inhibition of the HER4/ErbB4 kinase. [electronic resource] by Qiu, Chen Tarrant, Mary K Choi, Sung Hee Sathyamurthy, Aruna Bose, Ron Banjade, Sudeep Pal, Ashutosh Bornmann, William G Lemmon, Mark A Cole, Philip A Leahy, Daniel J Producer: 20080610 In: Structure (London, England : 1993) vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	718.	[Renal tolerance of targeted therapies]. [electronic resource] by Thariat, Juliette Janus, Nicolas Barrière, Jérôme Launay-Vacher, Vincent Producer: 20120425 In: Bulletin du cancer vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	719.	Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]. [electronic resource] by Hamilton, Erika Blackwell, Kimberly Hobeika, Amy C Clay, Timothy M Broadwater, Gloria Ren, Xiu-Rong Chen, Wei Castro, Henry Lehmann, Frederic Spector, Neil Wei, Junping Osada, Takuya Lyerly, H Kim Morse, Michael A Producer: 20120518 In: Journal of translational medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	720.	OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: a role for Nck1 but not Nck2. [electronic resource] by West, N Winston Garcia-Vargas, Aileen Chalfant, Charles E Park, Margaret A Producer: 20131126 In: BMC cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.